Nov 12
Technology holds up to 5 technology names above $500M. Selection weighs the model's positive score and its volatility score together.
Equal capital goes into every recommendation. Recommendations are published a few hours before the open and placed as market orders, so buys and sells fill at the opening price. There is no maximum holding period: a position exits when the model no longer selects it or when the stop is hit. Every position carries a 25% stop-loss: if the price touches it during the day, the position is sold there, at 75% of its entry price. Reported returns are measured from those opening prices and include every stop-loss exit.
Rubrik announced it will report Q3 fiscal 2027 results after market close on Nov 30, 2026, with a conference call at 5:00 pm ET. Per commentary, near-term share moves hinge on net new subscription ARR at this print, making it the key short-term catalyst.
Business WireRenewed momentum in the AI complex, following stronger-than-expected results from AI infrastructure names, drove a ~7.5% single-day gain on Nov 11, pushing FROG through its prior 52-week high of $108.59 to around $111.31. The breakout removes a near-term technical hurdle and reflects continued follow-through from the Q3 beat-and-raise, though the extended move raises pullback risk.
TickeronBaron's Q3 2026 investor letter disclosed that Netskope contributed 0.93% to returns at the Baron SMID Cap ETF, citing 27% year-over-year ARR growth, revenue growth of 29%, an 11-point operating margin improvement, and a raised full-year guidance. Institutional endorsement plus fundamental momentum narrative can attract momentum and fund flows in the near term.
Dealroom.coNTSK traded up about 5.18% intraday to $22.55, holding above its weekly (~$22.01) and quarterly (~$18.49) moving averages after consolidating in the $21-22 range. Technical strength and volume expansion raise the probability of a retest of the late-October high near $26.52, though weakening MACD momentum is a caveat.
CMoneyRubrik unveiled advanced cyber investigation/recovery capabilities for AWS workloads and announced GA of Autonomous Business Recovery for AWS Cloud Applications, extended to EKS, ECR, Lambda, and S3. Positive for medium-term adoption but likely feeds into future quarters rather than near-term numbers.
Rubrik Investor RelationsRubrik extended Google Cloud data protection to Google Cloud Storage and announced GA of agentless, immutable backup for Google BigQuery. Broadens platform coverage; incremental positive sentiment but limited near-term financial impact.
Rubrik Investor RelationsRubrik introduced cyber recovery capabilities for Microsoft Azure DevOps and GitHub, including anomaly detection, blast radius investigation, and surgical recovery. Expands addressable market; positive but medium-term adoption driver.
Rubrik Investor RelationsRoyal Bank of Canada raised its price target on Netskope from $20 to $23 while keeping an "outperform" rating, implying roughly 8% upside from the prior close. Sell-side target revisions of this kind typically draw incremental buyers and reinforce the "Moderate Buy" consensus (average target ~$19.82), supporting near-term sentiment.
MarketBeatTD Cowen maintained Buy and lifted its price target to $36 from $31, while the average 12-month target rose to $29 from $25.86 with a Buy consensus (five Buy, two Hold). Upward estimate/target revisions following the Q3 beat can drive near-term buying interest.
TradingView NewsSeaport Global upgraded SiTime to Buy from Neutral with a $425 price target on November 6, calling the ~50% post-earnings pullback an attractive entry point and citing an intact AI infrastructure buildout. The upgrade drove a 16% single-day rally, supporting near-term positive momentum.
Yahoo Finance / Investing.comJFrog reported Q3 2026 revenue of $179.2M (+31% YoY) and non-GAAP EPS of $0.32, beating consensus of ~$165.8M and $0.23. Cloud revenue grew 60% to $101.5M, NDR rose to 124%, and FY2026 guidance of $680-682M revenue and $1.14-1.16 EPS came in well above consensus (~$650.7M and $0.98). The beat-and-raise drove a sharp positive reaction, with shares jumping over 20% after hours and in the following session.
JFrog Investor Relations (Business Wire)On the Q3 2026 earnings call, management disclosed a $76M multiyear SaaS agreement with a leading global telecommunications company, representing 167% growth in cloud data consumption versus the prior commitment, with expansion into AI security and governance. The large deal size and expansion signal durable enterprise demand, reinforcing the positive post-earnings narrative.
The Motley Fool (Earnings Call Transcript)Needham cut its target to $600 from $900, Stifel to $750 from $800, Morgan Stanley to $640 from $730, and UBS to $650 from $750, all maintaining bullish ratings. The recalibrations signal tempered near-term expectations despite constructive long-term views, a mild negative for sentiment.
Yahoo Finance / Investing.comManagement acknowledged wafer constraints, particularly in the acquired TPD business, that could persist through 2027, with severe shortages easing by early next year. Persistent supply limits could cap revenue upside and weigh on sentiment despite strong demand.
Zacks / Yahoo FinanceSchrödinger reported Q3 2026 total revenue of $64.5M (+19% YoY), ACV of $44.7M (+17%), and drug discovery revenue of $24.2M, then raised FY2026 ACV guidance to $222–232M and drug discovery revenue to $75–85M. The beat-and-raise supports positive near-term sentiment and underpins analyst target increases.
Schrödinger Press ReleaseSchrödinger amended its Novartis collaboration, replacing programs and increasing potential milestone payments to $1.424B; Bristol Myers Squibb also adopted its Bunsen platform. Expanded partnership economics reinforce the platform's commercial validation and support sentiment.
TradingView NewsSchrödinger filed an 8-K correcting its ASH abstract, clarifying it has not initiated a combination study of SGR-1505 under its FDA-cleared protocol and is exploring strategic opportunities to continue development. The correction could temper expectations around the MALT1 program ahead of the December data readout.
SEC Filing (8-K)Updated Phase 1 data for zilemaltib (SGR-1505) in relapsed/refractory B-cell malignancies will be presented in an oral session at the ASH Annual Meeting (Dec 12–15, 2026), with dose escalation complete. This is a near-term binary catalyst that could move shares depending on safety/efficacy results.
Schrödinger Press ReleaseNetskope will report fiscal third quarter 2027 results (quarter ended October 31, 2026) after the close on December 2, 2026, with a call at 5:00 pm ET. The confirmed date focuses investor attention on the print; company guidance is for a Q3 loss of $0.04 to $0.03 per share, so positioning and any pre-earnings estimate revisions are the near-term drivers.
Netskope Press ReleaseSiTime reported Q3 2026 revenue of $298.7M (up 257% YoY) and non-GAAP EPS of $4.01, beating consensus of ~$3.63/$3.41 and $292M. Management cited broad-based growth and AI infrastructure demand, with annualized run-rate above $1B. The beat reinforces the bull case and supports near-term momentum.
SiTime Press ReleaseSiTime announced a 3-for-1 forward stock split, with record date December 3, 2026 and split-adjusted trading beginning December 7, 2026. Splits often boost retail interest and liquidity, providing a modest positive sentiment catalyst into early December.
SiTime Press ReleaseManagement guided Q4 2026 revenue to $331M-$341M with ~70% non-GAAP gross margin and ~$4.76 EPS at the midpoint, with both core and TPD businesses growing sequentially. Strong forward guidance supports near-term estimates and sentiment.
Zacks / Yahoo FinanceMajor shareholder Lightspeed Venture Partners sold 10,621 shares at an average price of $14.90 (~$158k) in a transaction dated September 11, 2026, disclosed via SEC filing. The size is small relative to the float and the disclosure is dated, so price impact is likely limited, but continued insider selling by a large holder is a mild overhang.
MarketBeat